271 related articles for article (PubMed ID: 27538692)
1. Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives.
Mirzaei H; Khataminfar S; Mohammadparast S; Sales SS; Maftouh M; Mohammadi M; Simonian M; Parizadeh SM; Hassanian SM; Avan A
Curr Med Chem; 2016; 23(36):4135-4150. PubMed ID: 27538692
[TBL] [Abstract][Full Text] [Related]
2. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers.
Jamali L; Tofigh R; Tutunchi S; Panahi G; Borhani F; Akhavan S; Nourmohammadi P; Ghaderian SMH; Rasouli M; Mirzaei H
J Cell Physiol; 2018 Nov; 233(11):8538-8550. PubMed ID: 29923196
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.
Mirzaei H; Gholamin S; Shahidsales S; Sahebkar A; Jaafari MR; Mirzaei HR; Hassanian SM; Avan A
Eur J Cancer; 2016 Jan; 53():25-32. PubMed ID: 26693896
[TBL] [Abstract][Full Text] [Related]
5. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs expression profiles as diagnostic biomarkers of gastric cancer: a systematic literature review.
Stojanovic J; Tognetto A; Tiziano DF; Leoncini E; Posteraro B; Pastorino R; Boccia S
Biomarkers; 2019 Mar; 24(2):110-119. PubMed ID: 30387681
[TBL] [Abstract][Full Text] [Related]
7. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
8. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
[TBL] [Abstract][Full Text] [Related]
9. Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.
Shekari N; Baradaran B; Shanehbandi D; Kazemi T
Curr Med Chem; 2018 Feb; 25(6):698-714. PubMed ID: 28971758
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA-133, microRNA-17 and microRNA-25 in serum and its potential diagnostic value in gastric cancer.
ZiaSarabi P; Sorayayi S; Hesari A; Ghasemi F
J Cell Biochem; 2019 Aug; 120(8):12376-12381. PubMed ID: 30861177
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.
Bertoli G; Cava C; Castiglioni I
Theranostics; 2015; 5(10):1122-43. PubMed ID: 26199650
[TBL] [Abstract][Full Text] [Related]
12. Plasma miR-940 may serve as a novel biomarker for gastric cancer.
Liu X; Kwong A; Sihoe A; Chu KM
Tumour Biol; 2016 Mar; 37(3):3589-97. PubMed ID: 26456959
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.
Moridikia A; Mirzaei H; Sahebkar A; Salimian J
J Cell Physiol; 2018 Feb; 233(2):901-913. PubMed ID: 28092102
[TBL] [Abstract][Full Text] [Related]
14. Let-7a Could Serve as A Biomarker for Chemo-Responsiveness to Docetaxel in Gastric Cancer.
Shekari N; Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
Anticancer Agents Med Chem; 2019; 19(3):304-309. PubMed ID: 30543177
[TBL] [Abstract][Full Text] [Related]
15. A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer.
Shin VY; Ng EK; Chan VW; Kwong A; Chu KM
Mol Cancer; 2015 Nov; 14():202. PubMed ID: 26607322
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer.
Aghdam AM; Amiri A; Salarinia R; Masoudifar A; Ghasemi F; Mirzaei H
Crit Rev Eukaryot Gene Expr; 2019; 29(2):127-139. PubMed ID: 31679268
[TBL] [Abstract][Full Text] [Related]
17. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.
Tsai MM; Wang CS; Tsai CY; Huang HW; Chi HC; Lin YH; Lu PH; Lin KH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322246
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of low miR-144 expression in gastric cancer.
Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
Cancer Biomark; 2017 Dec; 20(4):547-552. PubMed ID: 28800316
[TBL] [Abstract][Full Text] [Related]
19. Tumor Expression of
Obermannova R; Redova-Lojova M; Vychytilova-Faltejskova P; Grell P; Cho WC; Sachlova M; Svoboda M; Vyzula R; Slaby O
Anticancer Res; 2018 Jun; 38(6):3719-3724. PubMed ID: 29848733
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
